Personalized Medicine: The Road Ahead
- 1 February 2011
- journal article
- review article
- Published by Elsevier BV in Clinical Breast Cancer
- Vol. 11 (1), 20-26
- https://doi.org/10.3816/cbc.2011.n.004
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trialThe Lancet Oncology, 2010
- Biological determinants of endocrine resistance in breast cancerNature Reviews Cancer, 2009
- The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancerBreast Cancer Research and Treatment, 2009
- A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancerNature Medicine, 2009
- Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancerProceedings of the National Academy of Sciences of the United States of America, 2008
- Which tools can I use in daily clinical practice to improve tailoring of treatment for breast cancer? The 2007 St Gallen guidelines and/or Adjuvant! OnlineAnnals of Oncology, 2008
- Concordance among Gene-Expression–Based Predictors for Breast CancerThe New England Journal of Medicine, 2006
- A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast CancerThe New England Journal of Medicine, 2004
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- ON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.1The Lancet, 1896